A Longitudinal Evaluation of Disease & Fibrosis Biomarkers in Different Groups of Heart Failure Patients to Enhance the Early Clinical Development of Compounds with Anti-fibrotic Activity in the Heart
A study using MRIs to look at the structure of the heart in people with heart failure
Sponsor: Bristol - Myers Squibb
Enrolling: Male and Female Patients
Study Length: 1 Years
IRB Number: AAAQ7711
Contact: Andrea Kim: 212-305-1368 / caccresearch@cumc.columbia.edu
Additional Study Information: This study will help evaluate the progression of heart disease in people with heart failure. This will be done using 2 MRI studies, as well as a few blood tests. Depending which group you fall into you will come in for either 3 or 4 visits and 1 phone call at the 1 year mark.
This study is closed
Investigator
Emily Tsai, MD
Do You Qualify?
Are you at least 40 years old? Yes No
Do you have Heart Failure? Yes No
Can an MRI be performed on you? Yes No
Do you have a pacemaker? Yes No
Have you had a heart transplant? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Andrea Kim
caccresearch@cumc.columbia.edu
212-305-1368
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE